Literature DB >> 16864836

Sodium valproate vs phenytoin in status epilepticus: a pilot study.

U K Misra1, Jayantee Kalita, Rajesh Patel.   

Abstract

Sixty-eight patients with convulsive status epilepticus (SE) were randomly assigned to two groups to study the efficacy of sodium valproate (VPA) and phenytoin (PHT). Seizures were aborted in 66% in the VPA group and 42% in the PHT group. As a second choice in refractory patients, VPA was effective in 79% and PHT was effective in 25%. The side effects in the two groups did not differ. Sodium valproate may be preferred in convulsive SE because of its higher efficacy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16864836     DOI： 10.1212/01.wnl.0000224880.35053.26

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  47 in total

1.  New treatment options in status epilepticus: a critical review on intravenous levetiracetam.

Authors:  Eugen Trinka; Judith Dobesberger
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

2.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

3.  Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures.

Authors:  Aatif M Husain; Jong W Lee; Bradley J Kolls; Lawrence J Hirsch; Jonathan J Halford; Puneet K Gupta; Yafa Minazad; Jennifer M Jones; Suzette M LaRoche; Susan T Herman; Christa B Swisher; Saurabh R Sinha; Adriana Palade; Keith E Dombrowski; William B Gallentine; Cecil D Hahn; Elizabeth E Gerard; Manjushri Bhapkar; Yuliya Lokhnygina; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-06       Impact factor: 10.422

4.  The status of intravenous valproate for status.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2007 Jul-Aug       Impact factor: 7.500

5.  Intravenous valproate for status epilepticus ... An effective, yet still merely empirical alternative!

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2008 May-Jun       Impact factor: 7.500

6.  Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

Authors:  Tracy Glauser; Shlomo Shinnar; David Gloss; Brian Alldredge; Ravindra Arya; Jacquelyn Bainbridge; Mary Bare; Thomas Bleck; W Edwin Dodson; Lisa Garrity; Andy Jagoda; Daniel Lowenstein; John Pellock; James Riviello; Edward Sloan; David M Treiman
Journal:  Epilepsy Curr       Date:  2016 Jan-Feb       Impact factor: 7.500

7.  Usefulness of intravenous lacosamide in status epilepticus.

Authors:  Estevo Santamarina; Manuel Toledo; Maria Sueiras; Miquel Raspall; Nadim Ailouti; Elena Lainez; Isabel Porta; R De Gracia; Manuel Quintana; Javier Alvarez-Sabín; Xavier Salas Puig Xavier Salas Puig
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

Review 8.  Recent developments in the diagnosis and treatment of status epilepticus.

Authors:  Megan Selvitelli; Frank W Drislane
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

Review 9.  Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients.

Authors:  Elizabeth L Alford; James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

10.  Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs.

Authors:  J Kalita; P P Nair; U K Misra
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.